SURVIE_Report_EN
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
Elisabeth Baugh, Ovarian Cancer Champion, to Retire
CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for ad... Read More »
CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for ad... Read More »